Skip to main content

Table 1 EVs participate in ALI/ARDS by regulating alveolar cells

From: Extracellular vesicles in the pathogenesis and treatment of acute lung injury

EVs source

Molecules

Target cells

Effect

References

Human epithelial cell-EVs

miR-320a and miR-221

Macrophages

Activated macrophage and facilitated the recruitment of immunomodulatory cells

[19]

Vascular endothelial cell-EVs

CD31+ EVs

Alveolar macrophages

Anti-inflammatory and profibrotic effects

[24]

Type II alveolar epithelial cell-EVs

CD74+ EVs

Alveolar macrophages

Pro-inflammatory and anti-fibrotic effects

[24]

Alveolar macrophages-EVs

SOCS1 and SOCS3

Alveolar epithelial cells

Suppressed allergic inflammation

[25, 78]

Serum-exosomes

miR-1298-5p

BEAS-2B cells

Evoked inflammation, inhibited cell proliferation, and induced cell permeability

[74]

T lymphocyte-derived EVs

Unknown

Airway epithelial cells

Reduced cell viability, promoted inflammatory cytokine production, and decreased anti-inflammatory cytokine levels

[77]

Plasma-exosomes

S100A9 protein

HPMECs

Inhibited ZO-1 and occludin, and activated p38 MAPK signaling pathway/disruption of the tight junctions and endothelial barrier

[81]

Circulating blood-exosomes

miR-1-3p

HUVECs

Inhibited cell proliferation, promoted apoptosis and cytoskeleton contraction, increased monolayer endothelial cell permeability and membrane injury

[82]

Plasma-exosomes

miR-210-3p

THP-1 macrophage; BEAS-2B cells; HLMVECs

Enhanced THP-1 macrophage inflammation, BEAS-2B cell apoptosis, and HLMVEC permeability by regulating autophagy and inflammation activation

[84]

Plasma-EVs

Surfactant protein C and GSDMD-p30

Pulmonary vascular endothelial cells

Induced inflammatory injury and cell death

[85]

MPMVEC-exosomes

Syndecan-1 protein

Lung tissues

Attenuated ALI and inhibited inflammation

[86]

Peripheral serum-exosomes

miR-155

Alveolar macrophages

Reduced SHIP1 and SOCS1, promoted macrophage proliferation and inflammation

[90]

Activated neutrophils-derived EVs

miR-30d-5p

Alveolar macrophages

Induced polarization and apoptosis of M1 macrophages

[91]

Alveolar epithelial cells-exosomes

miR-92a-3p

Alveolar macrophages

Induced pulmonary inflammation

[92]

Alveolar epithelial cells-exosomes

miRNA

Alveolar macrophages

Activated inflammasomes and promoted lung inflammation

[93]

Lung epithelial cell-EVs

Caspase-3

Alveolar macrophages

Activated macrophages via the ROCK1 pathway

[94]

Dust bacteria

Unknown

Airway epithelial cells

Increased the inflammatory cytokines and neutrophil infiltration

[99]

Platelet

Unknown

Neutrophils

Mediated NETs formation

[100]

Neutrophils

Unknown

Platelet

Promoted platelet activation

[101]

Platelet

IL-1β and caspase-1

Neutrophils

Attracted platelet-neutrophile aggregates

[102]

Neutrophils

Neutrophil elastase and α−1 antitrypsin-resistance

Lung tissues

Destroyed lung extracellular matrix and alveolar structure

[103]

  1. ALI acute lung injury, ARDS acute respiratory distress syndrome, BEAS-2B human bronchial epithelial cells, EVs extracellular vesicles, HLMVECs human lung microvascular endothelial cells, HPMECs human pulmonary microvascular endothelial cells, HUVECs human umbilical vein endothelial cells, IL-1β interleukin-1β, MPMVECs mouse pulmonary microvascular endothelial cells, NETs neutrophil extracellular traps, SHIP1 SH2 domain-containing inositol phosphatese1, SOCS1 suppressor of cytokine signaling 1, SOCS3 suppressor of cytokine signaling 3, S100A9 S100 calcium binding protein A9, ZO-1 zonula occludens-1